Abstract
Objectives: We perform transvaginal intrafetal lidocaine injections to induce fetal demise at the time of dilator placement prior to induced abortion. We evaluated this method's efficacy by injection location, lidocaine dose, and other factors.
Highlights
To estimate feasibility, acceptability, and effectiveness of medication abortion with mifepristone dispensed by mail-order pharmacy
We conducted a population-based study of individuals who self-managed an abortion between June 1st and June 30th, 2020 using misoprostol obtained from Aid Access, an online telemedicine organization serving US residents
The main outcomes were the proportion of people who reported ending their pregnancy without surgical intervention and the proportion who received treatment for serious adverse events
Summary
Canada was positioned to transition to telemedicine abortion care during the COVID-19 pandemic because REMs-like mifepristone restrictions were removed previously. We sought to characterize the impact of the pandemic response on Canadian clinical practice and abortion care access from the provider perspective. Methods: This was a sequential mixed methods study conducted between July 2020 and January 2021. A national sample of abortion providers completed a survey containing an open-ended question about the impact of the pandemic response.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
